The hazard of fondaparinux in non-critically ill patients with COVID-19: Retrospective controlled study versus enoxaparin
Paolo Prandoni, Anna Maria Cattelan, Laura Carrozzi, Lucia Leone, Lucia Filippi, Egidio De Gaudenzi, Sabina Villalta, Raffaele Pesavento
Topics & Concepts
MedicineInternal medicineIncidence (geometry)Coronavirus disease 2019 (COVID-19)FondaparinuxDiseaseVenous thromboembolismThrombosisInfectious disease (medical specialty)OpticsPhysicsVenous Thromboembolism Diagnosis and ManagementCOVID-19 Clinical Research StudiesHeparin-Induced Thrombocytopenia and Thrombosis